Table 3.
Univariate Analysis of Association Between Outcome of COVID-19 with Age, Gender, Comorbidities and Vit D Insufficiency and Deficiency
| Variable | Outcome | |||||
|---|---|---|---|---|---|---|
| Hospital Stay (Days) Median (IQR)* | ICU Admission n (%)** | Ventilation n (%)** | Mortality n (%)** | |||
| Gender | Male | 11 (6–17) | 33 (28.7%) | 16 (13.9%) | 8 (7%) | |
| Female | 10 (6–15) | 19 (21.6%) | 7 (8%) | 8 (9.1%) | ||
| p-values | 0.4 | 0.25 | 0.19 | 0.6 | ||
| Age | ≤ 40 | 6.5 (4–11) | 8 (16.7%) | 1 (2.1%) | 0 | |
| > 40 | 11 (7–17) | 42 (28.6%) | 22 (15%) | 16 (10.9%) | ||
| p-values | <0.0001 | 0.102 | 0.016 | 0.017 | ||
| Diabetes Mellitus | Yes | 10 (7–17) | 36 (30.7%) | 18 (15.4%) | 12 (10.3%) | |
| No | 9 (6–14) | 16 (18.6%) | 5 (5.8%) | 4 (4.7%) | ||
| p-values | 0.16 | 0.05 | 0.034 | 0.14 | ||
| Hypertension | Yes | 11 (7–17) | 20 (28.6%) | 12 (17.1%) | 11 (15.7%) | |
| No | 9 (5–15) | 32 (24.1%) | 11 (8.3%) | 5 (3.8%) | ||
| p-values | 0.018 | 0.5 | 0.06 | 0.003 | ||
| Cardiac disease | Yes | 10 (7–16.5) | 7 (29.2%) | 4 (16.7%) | 5 (20.3%) | |
| No | 10 (6–16) | 45 (25.1%) | 19 (10.6%) | 11 (6.1%) | ||
| p-values | 0.53 | 0.7 | 0.4 | 0.012 | ||
| CKD | Yes | 10 (6.5–16) | 6 (31.6%) | 2 (10.5%) | 3 (15.8%) | |
| No | 10 (6–16) | 46 (25%) | 21 (11.4%) | 13 (7.1%) | ||
| p-values | 0.56 | 0.5 | 0.9 | 0.2 | ||
| CRD | Yes | 9 (6–21) | 3 (17.4%) | 2 (11.7%) | 2 (11.7%) | |
| No | 10 (6–16) | 49 (26.3%) | 21 (11.2%) | 14 (7.5%) | ||
| p-values | 0.89 | 0.4 | 0.9 | 0.5 | ||
| Vitamin D | Deficiency | 10 (5–17) | 38 (29.9%) | 18 (14.2%) | 13 (10.2%) | |
| Insufficiency | 11 (7–16) | 8 (17.8%) | 2 (4.4%) | 1 (2.2%) | ||
| p-values | 0.5 | 0.11 | 0.08 | 0.09 | ||
Note: *p values were calculated by: Mann Whitney U-test, **by Chi-Square test.
Abbreviations: ICU, intensive care units; CKD, chronic kidney diseases; CRD, chronic respiratory diseases; IQR, interquartile range; n, number.